Curaleaf Holdings (CURLF) Return on Assets Growth (3y) (2023 - 2024)

Curaleaf Holdings (CURLF) Return on Assets Growth (3y) (2023 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.86 Bn	42.90 Bn	-
2	Teva Pharmaceutical Industries	43.19 Bn	39.54 Bn	2.15 Bn
3	Zoetis	31.46 Bn	29.79 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.57 Bn	22.77 Bn	5.10 Bn
5	United Therapeutics	22.15 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn
8	Elanco Animal Health	11.71 Bn	11.18 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Curaleaf Holdings	2.50 Bn	2.40 Bn	169.91 Mn

Download Data